CareDx, Inc.
CareDx, Inc. (Nasdaq: CDNA) is a precision medicine company focused on transplant care, providing molecular diagnostic tests, laboratory products, digital health technologies, and patient services to transplant clinicians, centers, patients, and caregivers. Its post-transplant tests include AlloSure Kidney, Heart, and… From the company’s description.
Over the twelve months to Sep 30, 2026, CareDx, Inc. reported revenue of $497.40M, up 38.9% from a year earlier, and net income of $128.63M. Its operating margin was 23.4%, and operations generated $69.02M in cash. In fiscal 2025, it reported revenue of $379.81M, up 13.8% from fiscal 2024, and a net loss of $21.35M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What CareDx, Inc. does
In the company’s own words
CareDx, Inc. (Nasdaq: CDNA) is a precision medicine company focused on transplant care, providing molecular diagnostic tests, laboratory products, digital health technologies, and patient services to transplant clinicians, centers, patients, and caregivers. Its post-transplant tests include AlloSure Kidney, Heart, and Lung, which use donor-derived cell-free DNA, and AlloMap Heart, which uses gene expression profiling; HeartCare combines the two heart tests. Other offerings include HLA typing and transplant-monitoring kits, specialized pharmacy services, and software for patient management, referrals, waitlists, outcomes tracking, and medication adherence. Its products also support stem-cell transplantation and cell therapy. CareDx operates as a single reportable segment. In 2025, it performed approximately 200,000 commercial tests at its Brisbane laboratory, and its software solutions were used in more than 170 U.S. transplant centers. Major brands include AlloSure, AlloMap, AlloSeq, Ottr, and MedActionPlan.
Company details
- Sector
- Health Care
- Industry (SIC)
- Health Services
- Headquarters
- BRISBANE, CA
- Fiscal year end
- December
- CIK
- 1217234
- SIC
- 8071
Financial performance, year by year
Fiscal 2014–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns CareDx, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · CareDx, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do CareDx, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of CareDx, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in CareDx, Inc.'s last four quarterly filings that the numbers alone won't show?”